Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al. The third international consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shankar-Hari M, Calandra T, Soares MP, Bauer M, Wiersinga WJ, Prescott HC, Knight JC, Baillie KJ, Bos LDJ, Derde LPG, et al. Reframing sepsis immunobiology for translation: towards informative subtyping and targeted Immunomodulatory therapies. Lancet Respir Med. 2024;12:323–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van der Poll T, Shankar-Hari M, Wiersinga WJ. The immunology of sepsis. Immunity. 2021;54:2450–64.

Article  PubMed  Google Scholar 

Li J, Shen L, Qian K. Global, regional, and National incidence and mortality of neonatal sepsis and other neonatal infections, 1990–2019. Front Public Health. 2023;11:1139832.

Article  PubMed  PubMed Central  Google Scholar 

Weng L, Xu Y, Yin P, Wang Y, Chen Y, Liu W, Li S, Peng JM, Dong R, Hu XY, et al. National incidence and mortality of hospitalized sepsis in China. Crit Care. 2023;27:84.

Article  PubMed  PubMed Central  Google Scholar 

Bauer M, Gerlach H, Vogelmann T, Preissing F, Stiefel J, Adam D. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis. Crit Care. 2020;24:239.

Article  PubMed  PubMed Central  Google Scholar 

Giamarellos-Bourboulis EJ, Aschenbrenner AC, Bauer M, Bock C, Calandra T, Gat-Viks I, Kyriazopoulou E, Lupse M, Monneret G, Pickkers P, et al. The pathophysiology of sepsis and precision-medicine-based immunotherapy. Nat Immunol. 2024;25:19–28.

Article  CAS  PubMed  Google Scholar 

Woznica EA, Inglot M, Woznica RK, Lysenko L. Liver dysfunction in sepsis. Adv Clin Exp Med. 2018;27:547–51.

Article  PubMed  Google Scholar 

Kounatidis D, Vallianou NG, Psallida S, Panagopoulos F, Margellou E, Tsilingiris D, Karampela I, Stratigou T, Dalamaga M. Sepsis-Associated acute kidney injury: where are we now?? Medicina (Kaunas). 2024;60:434.

Legrand M, Bagshaw SM, Bhatraju PK, Bihorac A, Caniglia E, Khanna AK, Kellum JA, Koyner J, Harhay MO, Zampieri FG, et al. Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trials. Crit Care. 2024;28:92.

Article  PubMed  PubMed Central  Google Scholar 

Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13:862–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weng L, Zeng XY, Yin P, Wang LJ, Wang CY, Jiang W, Zhou MG, Du B, China Critical Care Clinical Trials G. Sepsis-related mortality in China: a descriptive analysis. Intensive Care Med. 2018;44:1071–80.

Article  PubMed  Google Scholar 

Fung KY, Louis C, Metcalfe RD, Kosasih CC, Wicks IP, Griffin MDW, Putoczki TL. Emerging roles for IL-11 in inflammatory diseases. Cytokine. 2022;149:155750.

Article  CAS  PubMed  Google Scholar 

Davidson AJ, Freeman SA, Crosier KE, Wood CR, Crosier PS. Expression of murine Interleukin 11 and its receptor alpha-chain in adult and embryonic tissues. Stem Cells. 1997;15:119–24.

Article  CAS  PubMed  Google Scholar 

Philips RL, Wang Y, Cheon H, Kanno Y, Gadina M, Sartorelli V, Horvath CM, Darnell JE Jr., Stark GR, O’Shea JJ. The JAK-STAT pathway at 30: much learned, much more to do. Cell. 2022;185:3857–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wan B, Zhang H, Fu H, Chen Y, Yang L, Yin J, Wan Y, Shi Y. Recombinant human interleukin-11 (IL-11) is a protective factor in severe sepsis with thrombocytopenia: A case-control study. Cytokine. 2015;76:138–43.

Article  CAS  PubMed  Google Scholar 

Maeshima K, Takahashi T, Nakahira K, Shimizu H, Fujii H, Katayama H, Yokoyama M, Morita K, Akagi R, Sassa S. A protective role of Interleukin 11 on hepatic injury in acute endotoxemia. Shock. 2004;21:134–8.

Article  CAS  PubMed  Google Scholar 

Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9:162–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sander LE, Sackett SD, Dierssen U, Beraza N, Linke RP, Muller M, Blander JM, Tacke F, Trautwein C. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J Exp Med. 2010;207:1453–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Movahedi K, Guilliams M, Van den Bossche J, Van den Bergh R, Gysemans C, Beschin A, De Baetselier P, Van Ginderachter JA. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood. 2008;111:4233–44.

Article  CAS  PubMed  Google Scholar 

De Cicco P, Ercolano G, Ianaro A. The new era of Cancer immunotherapy: targeting Myeloid-Derived suppressor cells to overcome immune evasion. Front Immunol. 2020;11:1680.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Condamine T, Gabrilovich DI. Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol. 2011;32:19–25.

Article  CAS  PubMed  Google Scholar 

Shi G, Li D, Zhang D, Xu Y, Pan Y, Lu L, Li J, Xia X, Dou H, Hou Y. IRF-8/miR-451a regulates M-MDSC differentiation via the AMPK/mTOR signal pathway during lupus development. Cell Death Discov. 2021;7:179.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brina D, Ponzoni A, Troiani M, Cali B, Pasquini E, Attanasio G, Mosole S, Mirenda M, D’Ambrosio M, Colucci M, et al. The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells. Nat Cancer. 2023;4:1102–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang W, Li X, Jiang M, Ji C, Chen G, Zhang Q, Liu P, Zhang R, Ren X, Yu W, Yu J. SOCS3 deficiency-dependent autophagy repression promotes the survival of early-stage myeloid-derived suppressor cells in breast cancer by activating the Wnt/mTOR pathway. J Leukoc Biol. 2023;113:445–60.

Article  CAS  PubMed  Google Scholar 

Marigo I, Bosio E, Solito S, Mesa C, Fernandez A, Dolcetti L, Ugel S, Sonda N, Bicciato S, Falisi E, et al. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity. 2010;32:790–802.

Article  CAS  PubMed  Google Scholar 

Lokau J, Agthe M, Flynn CM, Garbers C. Proteolytic control of Interleukin-11 and Interleukin-6 biology. Biochim Biophys Acta Mol Cell Res. 2017;1864:2105–17.

Article  CAS  PubMed  Google Scholar 

Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc. 2009;4:31–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao L, An R, Yang Y, Yang X, Liu H, Yue L, Li X, Lin Y, Reiter RJ, Qu Y. Melatonin alleviates brain injury in mice subjected to cecal ligation and puncture via attenuating inflammation, apoptosis, and oxidative stress: the role of SIRT1 signaling. J Pineal Res. 2015;59:230–9.

Article  CAS  PubMed  Google Scholar 

Volarevic V, Mitrovic M, Milovanovic M, Zelen I, Nikolic I, Mitrovic S, Pejnovic N, Arsenijevic N, Lukic ML. Protective role of IL-33/ST2 axis in Con A-induced hepatitis. J Hepatol. 2012;56:26–33.